| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tryp Therapeutics Inc (CN: TRYP)
TRYP Technical Analysis
5
| As on 7th Jul 2023 TRYP SHARE Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.14 & Strong Sell for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TRYPSHARE Price
| Open | 0.08 | Change | Price | % |
| High | 0.08 | 1 Day | 0.00 | 0.00 |
| Low | 0.08 | 1 Week | 0.02 | 33.33 |
| Close | 0.08 | 1 Month | 0.00 | 0.00 |
| Volume | 7500 | 1 Year | -0.15 | -65.22 |
| 52 Week High 0.27 | 52 Week Low 0.06 | ||||
CN Canada Most Active Stocks
| PUMP | 0.02 | 0.00% |
| CAT | 0.03 | -25.00% |
| ACDC | 0.06 | 0.00% |
| RFR | 0.02 | 0.00% |
| FMAN | 0.55 | 7.84% |
| EMER | 0.14 | -30.00% |
| TCF | 0.36 | -5.26% |
| CURA | 5.08 | -5.05% |
| RVV | 0.02 | -33.33% |
| TRIP | 0.09 | 0.00% |
CN Canada Top Gainers Stocks
CN Canada Top Losers Stocks
| TRYP Daily Charts |
TRYP Intraday Charts |
Whats New @ Bazaartrend |
TRYP Free Analysis |
|
|
TRYP Important Levels Intraday
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.08 |
TRYP Forecast April 2024
| 4th UP Forecast | 0.33 |
| 3rd UP Forecast | 0.25 |
| 2nd UP Forecast | 0.2 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.09 |
| 4th DOWN Forecast | -0.17 |
TRYP Weekly Forecast
| 4th UP Forecast | 0.21 |
| 3rd UP Forecast | 0.17 |
| 2nd UP Forecast | 0.14 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.05 |
TRYP Forecast2024
| 4th UP Forecast | 0.5 |
| 3rd UP Forecast | 0.37 |
| 2nd UP Forecast | 0.28 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.04 |
| 2nd DOWN Forecast | -0.12 |
| 3rd DOWN Forecast | -0.21 |
| 4th DOWN Forecast | -0.34 |
Tryp Therapeutics Inc ( CN Canada Symbol : TRYP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TRYP Business Profile
Tryp Therapeutics Inc., a clinical stage pharmaceutical company, focuses on developing compounds with known activity and/or safety profiles for the treatment of rare or orphan diseases and other diseases. The company's lead development program is psilocybin-for-neuropsychiatry (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 for fibromyalgia, hyperphagia in prader-willi syndrome, and other therapies; and TRP-1001, an oral formulation of razoxane evaluating for the treatment of soft tissue sarcoma. Tryp Therapeutics Inc. has an agreement with the University of Michigan to perform research related to its psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and training for the psychotherapeutic portion of Tryp's clinical trial activities. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was founded in 2019 and is headquartered in Kelowna, Canada. Address: 1665 Ellis Street, Kelowna, BC, Canada, V1Y 2B3
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service